{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T18:14:40Z","timestamp":1769969680826,"version":"3.49.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,6,30]],"date-time":"2020-06-30T00:00:00Z","timestamp":1593475200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,30]],"date-time":"2020-06-30T00:00:00Z","timestamp":1593475200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1007\/s11239-020-02069-9","type":"journal-article","created":{"date-parts":[[2020,6,30]],"date-time":"2020-06-30T08:02:49Z","timestamp":1593504169000},"page":"867-873","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Safety and efficacy of short-term (1 to 3\u00a0months) dual antiplatelet therapy in patients undergoing percutaneous coronary interventions: a meta-analysis of randomized controlled trials"],"prefix":"10.1007","volume":"50","author":[{"given":"Babikir","family":"Kheiri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy F.","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed","family":"Osman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harsh","family":"Golwala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qais","family":"Radaideh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kris","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hind","family":"Rahmouni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Punag","family":"Divanji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joaquin E.","family":"Cigarroa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Firas","family":"Zahr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,6,30]]},"reference":[{"issue":"9","key":"2069_CR1","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1161\/circulationaha.111.058560","volume":"125","author":"L R\u00e4ber","year":"2012","unstructured":"R\u00e4ber L, Magro M, Stefanini GG et al (2012) Very late coronary stent thrombosis of a newer-generation everolimus-eluting stent compared with early-generation drug-eluting stents. Circulation 125(9):1110\u20131121. https:\/\/doi.org\/10.1161\/circulationaha.111.058560","journal-title":"Circulation"},{"issue":"8","key":"2069_CR2","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1161\/circulationaha.105.600155","volume":"113","author":"PK Kuchulakanti","year":"2006","unstructured":"Kuchulakanti PK, Chu WW, Torguson R et al (2006) Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel-eluting stents. Circulation 113(8):1108\u20131113. https:\/\/doi.org\/10.1161\/circulationaha.105.600155","journal-title":"Circulation"},{"key":"2069_CR3","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1093\/eurheartj\/ehx419","volume":"39","author":"M Valgimigli","year":"2018","unstructured":"Valgimigli M, Bueno H, Byrne RA et al (2018) 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: the Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 39:213\u2013260","journal-title":"Eur Heart J"},{"key":"2069_CR4","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1016\/j.jacc.2016.03.513","volume":"68","author":"GN Levine","year":"2016","unstructured":"Levine GN, Bates ER, Bittl JA et al (2016) 2016 ACC\/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol 68:1082\u20131115","journal-title":"J Am Coll Cardiol"},{"key":"2069_CR5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1908419","author":"R Mehran","year":"2019","unstructured":"Mehran R, Baber U, Sharma S et al (2019) Ticagrelor with or without aspirin in high-risk patients after PCI. N Engl J Med. https:\/\/doi.org\/10.1056\/NEJMoa1908419","journal-title":"N Engl J Med"},{"issue":"4","key":"2069_CR6","doi-asserted-by":"publisher","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","volume":"151","author":"D Moher","year":"2009","unstructured":"Moher D (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 151(4):264","journal-title":"Ann Intern Med"},{"issue":"1","key":"2069_CR7","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jclinepi.2007.03.013","volume":"61","author":"J Wetterslev","year":"2008","unstructured":"Wetterslev J, Thorlund K, Brok J, Gluud C (2008) Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis. J Clin Epidemiol 61(1):64\u201375. https:\/\/doi.org\/10.1016\/j.jclinepi.2007.03.013","journal-title":"J Clin Epidemiol"},{"issue":"24","key":"2069_CR8","doi-asserted-by":"publisher","first-page":"2414","DOI":"10.1001\/jama.2019.8145","volume":"321","author":"H Watanabe","year":"2019","unstructured":"Watanabe H, Domei T, Morimoto T et al (2019) Effect of 1-month dual antiplatelet therapy followed by clopidogrel vs 12-month dual antiplatelet therapy on cardiovascular and bleeding events in patients receiving PCI. JAMA 321(24):2414. https:\/\/doi.org\/10.1001\/jama.2019.8145","journal-title":"JAMA"},{"issue":"24","key":"2069_CR9","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.1001\/jama.2019.8146","volume":"321","author":"J Hahn","year":"2019","unstructured":"Hahn J, Song YB, Oh J et al (2019) Effect of P2Y12 inhibitor monotherapy vs dual antiplatelet therapy on cardiovascular events in patients undergoing percutaneous coronary intervention: The SMART-CHOICE Randomized Clinical Trial. JAMA 321(24):2428\u20132437. https:\/\/doi.org\/10.1001\/jama.2019.8146","journal-title":"JAMA"},{"issue":"15","key":"2069_CR10","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1016\/j.jacc.2012.06.043","volume":"60","author":"M-K Hong","year":"2012","unstructured":"Hong M-K, Kim B-K, Shin D-H et al (2012) A new strategy for discontinuation of dual antiplatelet therapy: real safety and efficacy of 3 months dual antiplatelet therapy following endeavor zotarolimus-eluting stent implantation. J Am Coll Cardiol 60(15):1340\u20131348","journal-title":"J Am Coll Cardiol"},{"issue":"23","key":"2069_CR11","doi-asserted-by":"publisher","first-page":"2510","DOI":"10.1001\/jama.2013.282183","volume":"310","author":"F Feres","year":"2013","unstructured":"Feres F, Costa RA, Abizaid A et al (2013) Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: The OPTIMIZE Randomized Trial. JAMA 310(23):2510\u20132522. https:\/\/doi.org\/10.1001\/jama.2013.282183","journal-title":"JAMA"},{"issue":"10151","key":"2069_CR12","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1016\/S0140-6736(18)31858-0","volume":"392","author":"P Vranckx","year":"2018","unstructured":"Vranckx P, Valgimigli M, J\u00fcni P et al (2018) Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial. Lancet 392(10151):940\u2013949. https:\/\/doi.org\/10.1016\/S0140-6736(18)31858-0","journal-title":"Lancet"},{"issue":"11","key":"2069_CR13","doi-asserted-by":"publisher","first-page":"e990","DOI":"10.4244\/EIJ-D-19-00539","volume":"15","author":"G De Luca","year":"2019","unstructured":"De Luca G, Damen SA, Camaro C et al (2019) Final results of the randomised evaluation of short-term dual antiplatelet therapy in patients with acute coronary syndrome treated with a new-generation stent (REDUCE trial). EuroIntervention 15(11):e990\u2013e998. https:\/\/doi.org\/10.4244\/EIJ-D-19-00539","journal-title":"EuroIntervention"},{"issue":"9","key":"2069_CR14","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1161\/CIRCULATIONAHA.111.058560","volume":"125","author":"L R\u00e4ber","year":"2012","unstructured":"R\u00e4ber L, Magro M, Stefanini G et al (2012) Very late coronary stent thrombosis of a newer-generation everolimus-eluting stent compared with early-generation drug-eluting stents: a prospective cohort study. Circulation 125(9):1110\u20131121","journal-title":"Circulation"},{"issue":"1","key":"2069_CR15","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1080\/20009666.2018.1562853","volume":"9","author":"M Barbarawi","year":"2019","unstructured":"Barbarawi M, Kheiri B, Zayed Y, Aburahma A, Osman M, Barbarawi O, Hicks M, Hassan M, Alkotob ML, Bachuwa G (2019) Best duration of dual antiplatelet therapy after drug-eluting stent implantation: an updated network meta-analysis of randomized controlled trials. J Community Hosp Intern Med Perspect 9(1):9\u201317. https:\/\/doi.org\/10.1080\/20009666.2018.1562853","journal-title":"J Community Hosp Intern Med Perspect"},{"issue":"12","key":"2069_CR16","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1093\/eurheartj\/ehq066","volume":"31","author":"Y Ozaki","year":"2010","unstructured":"Ozaki Y, Okumura M, Ismail TF et al (2010 Jun) The fate of incomplete stent apposition with drug-eluting stents: an optical coherence tomography-based natural history study. Eur Heart J 31(12):1470\u20131476","journal-title":"Eur Heart J"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-020-02069-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11239-020-02069-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-020-02069-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T23:25:59Z","timestamp":1625009159000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11239-020-02069-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,30]]},"references-count":16,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["2069"],"URL":"https:\/\/doi.org\/10.1007\/s11239-020-02069-9","relation":{},"ISSN":["0929-5305","1573-742X"],"issn-type":[{"value":"0929-5305","type":"print"},{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,30]]},"assertion":[{"value":"30 June 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human and animal participants"}}]}}